HealthEquity (NASDAQ:HQY) Sets New 1-Year High – Should You Buy?

Shares of HealthEquity, Inc. (NASDAQ:HQY) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $107.89 and last traded at $107.55, with a volume of 352393 shares. The stock had previously closed at $104.34.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Barrington Research lifted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Bank of America boosted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. JMP Securities boosted their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Finally, BTIG Research increased their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Stock Up 3.2 %

The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm’s fifty day moving average is $99.74 and its 200 day moving average is $87.87. The stock has a market cap of $9.33 billion, a P/E ratio of 98.82, a P/E/G ratio of 1.86 and a beta of 0.54.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the firm posted $0.40 EPS. As a group, equities research analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Transactions at HealthEquity

In other news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at $363,642.40. The trade was a 21.54 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,289 shares of company stock worth $3,355,718. Insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently bought and sold shares of the business. Wasatch Advisors LP raised its holdings in shares of HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after buying an additional 483,269 shares in the last quarter. Vaughan Nelson Investment Management L.P. raised its stake in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after acquiring an additional 226,563 shares in the last quarter. Barclays PLC lifted its holdings in shares of HealthEquity by 209.3% during the third quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after acquiring an additional 112,667 shares during the period. Thrivent Financial for Lutherans boosted its stake in shares of HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after purchasing an additional 73,404 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of HealthEquity in the 3rd quarter worth about $5,675,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.